Hollo is a health-tech social enterprise founded in Hong Kong, supported by Microsoft, Cyberport, HK ITF, and the SIE Fund HK. The company's core mission is to improve the mental health of chronic patients through AI-driven digital therapeutics. Hollo offers clinical-grade software that measures, tracks, and treats mental health conditions, integrating with healthcare providers to enhance treatment adherence and gamify patient data recording. Their market focus is on providing accessible mental health solutions within the healthcare ecosystem.
Notable affiliated individuals include professionals from healthcare, psychology, game design, data science, and software development. Hollo has garnered support from significant investors and organizations, reflecting its innovative approach and potential impact. Key achievements include developing a pipeline of digital therapeutics and software medical devices aimed at transforming chronic care management. Hollo's overall impact lies in its potential to revolutionize mental health treatment for chronic patients, aiming for regulatory approvals like FDA certification.
